CYP19A1 and polycystic ovary syndrome: Moreover, low-frequency EA reduced ovarian androgen synthase expression, increased aromatase expression [48], regulated local ovarian factor and gonadotropin receptor expression [38, 49], and enhanced insulin sensitivity in PCOS rats [50].